Fate Therapeutics Inc (NASDAQ:FATE) is held by 139 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | -504,240 | -4.72% | $0.00 |
| Redmile Group, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 0 | -790,000 | -31.41% | $0.00 |
| Johnson & Johnson | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 172,856 | 1.96% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | 1,527,986 | 0.00% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -326,222 | -51.39% | $0.00 |
| Monaco Asset Management SAM | 31 Dec, 2025 | 0 | 60,000 | 7.79% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 97,566 | 99.76% | $0.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 0 | 221,659 | 8.18% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 88,765 | 28.20% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | -61,864 | -2.45% | $0.00 |
| Privium Fund Management B.V. | 31 Dec, 2025 | 0 | 35,881 | 10.77% | $0.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 0 | 1,098,366 | 87.00% | $0.00 |
| Knott David M Jr | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | -151,918 | -6.29% | $0.00 |
| XTX Topco Ltd | 31 Dec, 2025 | 0 | 364,738 | 0.00% | $0.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Dec, 2025 | 0 | 833,307 | 92.51% | $0.00 |
| Woodline Partners LP | 31 Dec, 2025 | 0 | -356,000 | -49.95% | $0.00 |
| TWO SIGMA ADVISERS, LP | 31 Dec, 2025 | 0 | 644,300 | 63.96% | $0.00 |